dc.contributor.author | Bese, N. S. | |
dc.contributor.author | Altinok, A. Y. | |
dc.contributor.author | Yildirim, S. | |
dc.contributor.author | Sut, N. | |
dc.contributor.author | Ober, A. | |
dc.contributor.author | Ozsahin, E. M. | |
dc.contributor.author | Azria, D. | |
dc.contributor.author | Altug, T. | |
dc.date.accessioned | 2021-03-04T12:21:03Z | |
dc.date.available | 2021-03-04T12:21:03Z | |
dc.identifier.citation | Altinok A. Y. , Yildirim S., Altug T., Sut N., Ober A., Ozsahin E. M. , Azria D., Bese N. S. , "Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study", BREAST, cilt.28, ss.174-177, 2016 | |
dc.identifier.issn | 0960-9776 | |
dc.identifier.other | av_76d934a4-23a2-44e0-9ebf-3fdc59badd87 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/81603 | |
dc.identifier.uri | https://doi.org/10.1016/j.breast.2016.04.003 | |
dc.description.abstract | Purpose: In experimental and clinical trials, tamoxifen (TAM) has been shown to increase radiation-induced lung fibrosis (RILF). Furthermore, aromatase inhibitors (AI) have been shown to be superior to TAM in the adjuvant setting and preclinical data suggest that letrozole (LET) sensitizes breast cancer cells to ionizing radiation in other studies. In this experimental study, we evaluated whether AI have any impact on the development of RILF in rats. | |
dc.language.iso | eng | |
dc.subject | KADIN HASTALIKLARI & DOĞUM | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Kadın Hastalıkları ve Doğum | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study | |
dc.type | Makale | |
dc.relation.journal | BREAST | |
dc.contributor.department | İstanbul Medipol Üniversitesi , , | |
dc.identifier.volume | 28 | |
dc.identifier.startpage | 174 | |
dc.identifier.endpage | 177 | |
dc.contributor.firstauthorID | 234286 | |